Danaher
Washington, D.C.-based conglomerate Danaher has been impressing stock analysts, so it doesn’t come as a surprise that it attracted Sandler Capital Management, who bet on the company in 2020. The firm has increased its stake in the medical brand by 35 percent.
Wall Street’s bullish outlook on Danaher makes sense if one looks at the healthcare brand’s recent moves. It acquired General Electric’s biopharma business, now called Cytiva, for a whopping $21 billion in March 2020. Apart from that, it is closely working with the government amid the pandemic, receiving $31 million in October to beef up the manufacture of products related to COVID-19 vaccines.
